First Episode Psychosis Clinical Trial
— NECT-YAOfficial title:
Development of a Stage-specific Adaptation of a Self-stigma Intervention for People Recovering From a First Episode of Psychosis
NCT number | NCT04889911 |
Other study ID # | JJayCuny |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | August 1, 2023 |
Est. completion date | September 2024 |
The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase treatment engagement. The specific aims of the project are to: 1) adapt NECT to be responsive to the needs and preferences of youth with FEP, and 2) Assess the feasibility, acceptability and preliminary effectiveness of the modified intervention (NECT-YA) combined with coordinated specialty care (CSC) services, compared to CSC services alone, in a small (n = 40) RCT.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | September 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 24 Years |
Eligibility | Inclusion Criteria: 1. Meets criteria for FEP youth based on the following definition: age 15-24, onset of psychotic symptoms within the last 5 years, and an absence of a primary substance use or mood disorder that could be causing the psychotic symptoms (confirmed by program eligibility); 2. Meets criteria for moderate (defined as a mean score of 1-1.5 on the 0-3 scale of the Internalized Stigma of Mental lllness Scale [ISMI]) or elevated (defined as a mean score of 1.5-3 on the 0-3 scale of the ISMI) self-stigma; 3. Speaks English well enough to complete assessments and participate in groups; 4. Is able to provide informed consent to participate. Exclusion Criteria: Does not meet any of the above inclusion criteria. |
Country | Name | City | State |
---|---|---|---|
United States | Eskenazi Health, PARC Program | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
John Jay College of Criminal Justice, City University of New York | Indiana University School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Internalized Stigma of Mental Illness Scale | A 29 item measure of internalized stigma. Higher scores indicate great internalized stigma. | 5 minutes | |
Other | Positive and Negative Syndrome Scale | The Positive and Negative Syndrome Scale is a 30-item rating scale of psychiatric symptoms associated with psychosis, completed following a chart review and semi-structured interview. Higher scores indicate more symptoms. | 20 minutes | |
Other | Recovery Style Questionnaire Recovery Style Questionnaire | The Recovery Style Questionnaire is a 39 item self-report scale designed to assess the extent to which people with psychosis engage in "sealing over" versus "integration" with regard to how their self-conception. | 5 minutes | |
Primary | Treatment Engagement | Quantity of service use will be measured using attendance records for groups collected by facilitators, as well as administrative data on total service use within the FEP programs. | 0 minutes | |
Primary | Working Alliance Inventory Short Form-Client Version | A 12-item self-report measure of perception of relationship with the treatment team. Higher scores indicate better working alliance. | 2 minutes | |
Primary | Coping with Symptoms Checklist | Assesses the use of problem-centered, neutral and avoidant coping strategies to deal with a variety of psychiatric symptoms commonly experienced by people with severe mental illnesses. Higher scores in each subscale indicate more use of that type of coping strategy. | 15 minutes | |
Secondary | Beck Hopelessness Scale | The Beck Hopelessness Scale is a well-established 20-item scale that will be used to measure pessimistic expectations of the future. Individual items are summed to provide an overall index of hope or its absence. Higher scores indicate less hope. | 3 minutes | |
Secondary | Rosenberg Self Esteem Scale | The Rosenberg Self Esteem Schedule will be used to measure self-esteem and self-deprecation. Higher scores indicate more self-esteem. | 2 minutes | |
Secondary | Quality of Life Scale | The Quality of Life Scale is a 21-item scale completed by clinically trained research staff following a semi-structured interview that assesses social functioning in multiple domains. Higher scores indicate great social functioning. | 20 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Completed |
NCT00202280 -
Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication
|
Phase 2/Phase 3 | |
Completed |
NCT01026584 -
Efficacy and Safety of Aripiprazole in First Episode Psychosis
|
Phase 4 | |
Completed |
NCT03983421 -
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
|
||
Recruiting |
NCT04046497 -
Artificial Intelligence to Measure Adherence to Oral Medication
|
Phase 4 | |
Withdrawn |
NCT04369677 -
Thermoregulation Among Individuals With First-episode Psychosis
|
||
Completed |
NCT03568500 -
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
|
Phase 4 | |
Completed |
NCT03102151 -
Reducing the Duration of Untreated Psychosis
|
||
Completed |
NCT00916461 -
Role of Minocycline in First Episode Psychosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT05310838 -
Optimizing Engagement in Services for First-Episode Psychosis
|
N/A | |
Completed |
NCT03501160 -
Socially Inappropriate Behaviour in People With First Episode Psychosis: A Caregivers' Perspective
|
||
Recruiting |
NCT03196128 -
Early Intervention Psychosis Communication and Engagement Trial
|
N/A | |
Recruiting |
NCT04005378 -
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
|
Phase 4 | |
Recruiting |
NCT03919760 -
Early Psychosis Intervention - Spreading Evidence-based Treatment
|
||
Completed |
NCT03409393 -
Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis
|
N/A | |
Completed |
NCT01753284 -
First Episode Psychosis and Pathway to Care in Nordland
|
||
Completed |
NCT01157585 -
Efficacy and Safety of Paliperidone ER in First Episode Psychosis
|
Phase 4 | |
Completed |
NCT05737966 -
Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist
|
||
Recruiting |
NCT04021719 -
OnTrackNY's Learning Healthcare System
|
||
Recruiting |
NCT04853485 -
Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes
|
N/A |